NovoCure Limited company logo
NovoCure Limited logo

NovoCure Limited (NVCR) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$163.77M$77.05M-32.00%

Summary

Current Value
As of today, NVCR annual cash & cash equivalents is $163.77M, down -32.00% on
Historical Performance
NVCR annual cash & cash equivalents is down -21.57% over the past 3 years, and down -7.64% over the past 5 years
All-Time High Comparison
NVCR annual cash & cash equivalents is currently -32.00% below its historical high of $240.82M set on
3-Year Low Comparison
NVCR annual cash & cash equivalents is +42.00% above its 3-year low of $115.33M reached on an earlier date
Sector Comparison
NVCR annual cash & cash equivalents is higher than 74.34% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NVCR Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$163.77M-32.0%-21.6%-7.6%-6.9%
Quarterly Cash & Cash Equivalents$1.04B+7.5%+6.8%+340.1%
Price$14.29-51.8%-86.9%-90.9%
Annual Current Assets$1.11B+7.0%+3.1%+151.5%+503.1%
Annual Total Liabilities$880.61M+12.4%+20.8%+236.6%+5040.1%
Annual Working Capital$350.20M-59.1%-62.4%-1.0%+108.6%
Annual Net Income-$168.63M+18.6%-189.0%-2232.3%-118.0%

Cash and Cash Equivalents Highs

NVCR Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$240.82M-32.0%
5Y$240.82M-32.0%
All$240.82M-32.0%

Cash and Cash Equivalents Lows

NVCR Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$115.33MN/A+42.0%
5Y$115.33M+42.0%
All$57.61M+184.3%

Cash and Cash Equivalents History

YearValueChange
$163.77M-32.0%
$240.82M+108.8%
$115.33M-44.8%
$208.80M-11.0%
$234.67M+32.3%
$177.32M+26.1%
YearValueChange
$140.62M+78.9%
$78.59M-21.2%
$99.78M-16.4%
$119.42M+107.3%
$57.61M-

FAQ

  • What is the current annual cash & cash equivalents of NVCR?

    As of today, NVCR annual cash & cash equivalents is $163.77M

  • What is 1-year change in NVCR annual cash & cash equivalents?

    NVCR annual cash & cash equivalents is down -32.00% year-over-year

  • What is 3-year change in NVCR annual cash & cash equivalents?

    NVCR annual cash & cash equivalents is down -21.57% over the past 3 years

  • How far is NVCR annual cash & cash equivalents from its all-time high?

    NVCR annual cash & cash equivalents is currently -32.00% below its historical high of $240.82M set on December 31, 2023

  • How does NVCR annual cash & cash equivalents rank versus sector peers?

    NVCR annual cash & cash equivalents is higher than 74.34% of companies in Healthcare sector

  • When is NVCR next annual earnings release?

    The next annual earnings release for NVCR is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. NVCR Official Website www.novocure.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1645113/000164511325000042/0001645113-25-000042-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1645113/000164511325000002/0001645113-25-000002-index.htm
  4. NVCR Profile on Yahoo Finance finance.yahoo.com/quote/NVCR
  5. NVCR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvcr